UTAH MEDICAL PRODUCTS INC
Calidad de datos: 100%
UTMD
Nasdaq
Manufacturing
Measuring & Analyzing Instruments
$65.47
▲
$0.94
(1.45%)
Cap. Mercado: 209.73 M
Precio
$65.47
Cap. Mercado
209.73 M
Rango del Día
$63.36 — $65.47
Rango de 52 Semanas
$51.26 — $68.71
Volumen
7,162
Apertura $63.40
Promedio 50D / 200D
$63.99
2.31% above
Promedio 50D / 200D
$59.86
9.36% above
Quick Summary
Puntos Clave
Revenue declined -5.86% annually over 5 years
Earnings declined -18.65% over the past year
Net margin of 29.30% shows strong profitability
Generating 14.32 M in free cash flow
Cash machine — converts 126.89% of earnings into free cash flow
Capital efficient — spends only 0.96% of revenue on capex
Crecimiento
Revenue Growth (5Y)
-5.86%
Below sector avg (1.82%)
Revenue (1Y)-5.83%
Earnings (1Y)-18.65%
FCF Growth (3Y)-18.65%
Calidad
Return on Equity
9.57%
Above sector avg (-53.41%)
ROIC7.68%
Net Margin29.30%
Op. Margin29.60%
Seguridad
Debt / Equity
N/A
Current Ratio32.06
Interest CoverageN/A
Valoración
PE (TTM)
18.58
Above sector avg (-1.48)
P/B Ratio1.77
EV/EBITDA11.00
Dividend YieldN/A
Historial de Precios
Tendencias Financieras
Comparación con Pares
vs mediana del sector Manufacturing (1364 pares)
Comparación con Pares
vs mediana del sector Manufacturing (1364 pares)| Métrica | Acción | Mediana del Sector |
|---|---|---|
| P/E | 18.6 | -1.5 |
| P/B | 1.8 | 1.6 |
| ROE % | 9.6 | -53.4 |
| Net Margin % | 29.3 | -41.5 |
| Rev Growth 5Y % | -5.9 | 1.8 |
| D/E | — | 0.3 |
All Fundamental Metrics
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -5.83% | Revenue Growth (3Y) | -12.42% |
| Earnings Growth (1Y) | -18.65% | Earnings Growth (3Y) | -17.63% |
| Revenue Growth (5Y) | -5.86% | Earnings Growth (5Y) | -6.53% |
| Profitability | |||
| Revenue (TTM) | 38.52 M | Net Income (TTM) | 11.29 M |
| ROE | 9.57% | ROA | 9.30% |
| Gross Margin | 57.12% | Operating Margin | 29.60% |
| Net Margin | 29.30% | Free Cash Flow (TTM) | 14.32 M |
| ROIC | 7.68% | FCF Growth (3Y) | -18.65% |
| Safety | |||
| Debt / Equity | N/A | Current Ratio | 32.06 |
| Interest Coverage | N/A | Asset Turnover | 0.32 |
| Working Capital | 93.52 M | Tangible Book Value | 102.81 M |
| Dividends | |||
| Dividend Yield | N/A | Payout Ratio | N/A |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | 18.58 | Forward P/E | N/A |
| P/B Ratio | 1.77 | P/S Ratio | 5.44 |
| PEG Ratio | N/A | Forward PEG | N/A |
| EV/EBITDA | 11.00 | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 6.83% | ||
| Market Cap | 209.73 M | Enterprise Value | 125.46 M |
| Per Share | |||
| EPS (Diluted TTM) | 3.48 | Revenue / Share | 12.02 |
| FCF / Share | 4.47 | OCF / Share | 4.59 |
| EPS CAGR (1Y) | -12.12% | EPS CAGR (5Y) | -3.66% |
| EPS CAGR (10Y) | 0.87% | ||
| Efficiency | |||
| CapEx / Revenue | 0.96% | FCF Conversion | 126.89% |
| SBC-Adj. FCF | 14.01 M | Growth Momentum | 0.03 |
Income Statement
Annual, most recent first
Income Statement
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 38.52 M | 40.90 M | 50.22 M | 52.28 M | 49.05 M |
| Net Income | 11.29 M | 13.87 M | 16.64 M | 16.47 M | 14.79 M |
| EPS (Diluted) | 3.48 | 3.96 | 4.57 | 4.52 | 4.04 |
| Gross Profit | 22.00 M | 24.14 M | 30.04 M | 32.20 M | 30.92 M |
| Operating Income | 11.40 M | 13.59 M | 16.78 M | 19.79 M | 18.88 M |
| EBITDA | — | — | — | — | — |
| R&D Expenses | 668,000.0 | 813,000.0 | 560,000.0 | 493,000.0 | 526,000.0 |
| SG&A Expenses | — | — | — | — | — |
| D&A | — | — | — | — | — |
| Interest Expense | — | — | — | — | — |
| Income Tax | 2.82 M | 2.93 M | 3.45 M | 4.19 M | 4.27 M |
Balance Sheet
Annual, most recent first
Balance Sheet
Annual, most recent first| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 122.54 M | 122.54 M | 135.46 M | 123.87 M | 115.64 M |
| Total Liabilities | 3.27 M | 5.11 M | 7.15 M | 9.62 M | 8.50 M |
| Shareholders' Equity | 119.27 M | 117.43 M | 128.31 M | 114.25 M | 107.14 M |
| Total Debt | 0.0 | 0.0 | 0.0 | 0.0 | 0.0 |
| Cash & Equivalents | 85.76 M | 82.98 M | 92.87 M | 75.05 M | 60.97 M |
| Current Assets | 97.74 M | 96.33 M | 106.27 M | 89.92 M | 73.16 M |
| Current Liabilities | 2.60 M | 3.76 M | 4.71 M | 5.96 M | 3.75 M |
{"event":"ticker_viewed","properties":{"ticker":"UTMD","listing_kind":"stock","pathname":"/stocks/utmd","exchange":"Nasdaq","country":"US"}}






